Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Masamitsu NishiTakashi KimuraMasataka IgetaMitsuru FurutaKoichi SuenagaTsuyoshi MatsumuraHarutoshi FujimuraKenji JinnaiHiroo YoshikawaPublished in: PloS one (2020)
Myotonic dystrophy type 1 (DM1) is a multi-system disorder caused by CTG repeats in the myotonic dystrophy protein kinase (DMPK) gene. This leads to the sequestration of splicing factors such as muscleblind-like 1/2 (MBNL1/2) and aberrant splicing in the central nervous system. We investigated the splicing patterns of MBNL1/2 and genes controlled by MBNL2 in several regions of the brain and between the grey matter (GM) and white matter (WM) in DM1 patients using RT-PCR. Compared with amyotrophic lateral sclerosis (ALS, as disease controls), the percentage of spliced-in parameter (PSI) for most of the examined exons were significantly altered in most of the brain regions of DM1 patients, except for the cerebellum. The splicing of many genes was differently regulated between the GM and WM in both DM1 and ALS. In 7 out of the 15 examined splicing events, the level of PSI change between DM1 and ALS was significantly higher in the GM than in the WM. The differences in alternative splicing between the GM and WM may be related to the effect of DM1 on the WM of the brain.
Keyphrases
- white matter
- end stage renal disease
- amyotrophic lateral sclerosis
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- genome wide
- early onset
- transcription factor
- protein kinase
- metabolic syndrome
- glycemic control
- patient reported outcomes
- dna methylation
- mass spectrometry
- insulin resistance
- copy number
- single molecule
- weight loss
- subarachnoid hemorrhage